Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.34 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.33 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.33 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.33 |
| ▸ | PGD | P52209 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1561853 | 0.94 | SMN1; SMN2 (0.46) | SMN1; SMN2TSHRALDH1A1SLC22A6CACNA2D1 | |
| Ether SCHEMBL2953322 | 0.92 | SMN1; SMN2 (0.35) | SMN1; SMN2TSHRALDH1A1 | |
| Ether SCHEMBL2959728 | 0.89 | TSHR (0.35) | SMN1; SMN2TSHR | |
| Ether SCHEMBL2961670 | 0.85 | TSHR (0.39) | SMN1; SMN2TSHR | |
| Ether SCHEMBL3021666 | 0.85 | TSHR (0.33) | SMN1; SMN2TSHR | |
| SCHEMBL669418 | 0.82 | SMN1; SMN2 (0.46) | SMN1; SMN2TSHRSLC22A6CACNA2D1CACNB3 | |
| SCHEMBL2961672 | 0.81 | SMN1; SMN2 (0.39) | SMN1; SMN2TSHRALDH1A1SLC22A6CACNA2D1 | |
| SCHEMBL18585754 | 0.78 | SMN1; SMN2 (0.43) | SMN1; SMN2ALDH1A1SLC22A6PGDGABRR1 | |
| SCHEMBL3030635 | 0.78 | TSHR (0.36) | TSHRALDH1A1 | |
| SCHEMBL2953324 | 0.78 | SMN1; SMN2 (0.39) | SMN1; SMN2TSHRALDH1A1SLC22A6CACNA2D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8562957-B2 | Oily hair cosmetics | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20100203003-A1 | Oily Hair Cosmetics | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2010-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100203003-A1 | Oily Hair Cosmetics | H1-0, H1-2, H1-3 | SMN1; SMN2 3778/4885TSHR 1973/4885ALDH1A1 2116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.